Mike Polark
Stock Analyst at Wolfe Research
(3.53)
# 801
Out of 4,835 analysts
72
Total ratings
50%
Success rate
6.05%
Average return
Main Sectors:
Stocks Rated by Mike Polark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Upgrades: Outperform | $350 | $324.75 | +7.78% | 4 | May 13, 2025 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $230 → $236 | $152.67 | +54.58% | 7 | May 6, 2025 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $133 → $150 | $141.00 | +6.38% | 8 | May 2, 2025 | |
| KMTS Kestra Medical Technologies | Initiates: Outperform | $29 | $24.63 | +17.74% | 1 | Mar 31, 2025 | |
| EW Edwards Lifesciences | Downgrades: Underperform | $60 | $78.00 | -23.08% | 4 | Jan 16, 2025 | |
| RMD ResMed | Downgrades: Underperform | $180 | $251.69 | -28.48% | 5 | Sep 18, 2024 | |
| ZBH Zimmer Biomet Holdings | Initiates: Peer Perform | n/a | $96.95 | - | 1 | Sep 10, 2024 | |
| SYK Stryker | Initiates: Outperform | $405 | $394.21 | +2.74% | 1 | Sep 10, 2024 | |
| LIVN LivaNova | Maintains: Neutral | $55 | $44.40 | +23.87% | 8 | Aug 28, 2024 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $487 → $503 | $563.60 | -10.75% | 7 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Peer Perform | n/a | $134.80 | - | 4 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $129.29 | - | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $121 | $85.48 | +41.55% | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $23.08 | - | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $25 | $12.80 | +95.31% | 4 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $165 | $155.62 | +6.03% | 3 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $106.04 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | n/a | $86.44 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $17.49 | -25.67% | 2 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | $21 | $6.24 | +236.54% | 1 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $250 | $251.59 | -0.63% | 2 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $43 | $1.55 | +2,674.19% | 1 | Sep 2, 2020 |
Insulet
May 13, 2025
Upgrades: Outperform
Price Target: $350
Current: $324.75
Upside: +7.78%
Inspire Medical Systems
May 6, 2025
Maintains: Outperform
Price Target: $230 → $236
Current: $152.67
Upside: +54.58%
iRhythm Technologies
May 2, 2025
Maintains: Outperform
Price Target: $133 → $150
Current: $141.00
Upside: +6.38%
Kestra Medical Technologies
Mar 31, 2025
Initiates: Outperform
Price Target: $29
Current: $24.63
Upside: +17.74%
Edwards Lifesciences
Jan 16, 2025
Downgrades: Underperform
Price Target: $60
Current: $78.00
Upside: -23.08%
ResMed
Sep 18, 2024
Downgrades: Underperform
Price Target: $180
Current: $251.69
Upside: -28.48%
Zimmer Biomet Holdings
Sep 10, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $96.95
Upside: -
Stryker
Sep 10, 2024
Initiates: Outperform
Price Target: $405
Current: $394.21
Upside: +2.74%
LivaNova
Aug 28, 2024
Maintains: Neutral
Price Target: $55
Current: $44.40
Upside: +23.87%
Intuitive Surgical
Jul 19, 2024
Maintains: Outperform
Price Target: $487 → $503
Current: $563.60
Upside: -10.75%
Jul 21, 2023
Upgrades: Peer Perform
Price Target: n/a
Current: $134.80
Upside: -
Apr 26, 2023
Downgrades: Peer Perform
Price Target: n/a
Current: $129.29
Upside: -
Jan 26, 2023
Initiates: Outperform
Price Target: $121
Current: $85.48
Upside: +41.55%
Jan 26, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $23.08
Upside: -
Jan 11, 2023
Upgrades: Outperform
Price Target: $25
Current: $12.80
Upside: +95.31%
Sep 15, 2022
Upgrades: Outperform
Price Target: $165
Current: $155.62
Upside: +6.03%
Jul 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $106.04
Upside: -
Jul 6, 2022
Initiates: Underperform
Price Target: n/a
Current: $86.44
Upside: -
Apr 6, 2022
Initiates: Outperform
Price Target: $13
Current: $17.49
Upside: -25.67%
Apr 6, 2022
Initiates: Peer Perform
Price Target: $21
Current: $6.24
Upside: +236.54%
Aug 11, 2021
Maintains: Outperform
Price Target: $230 → $250
Current: $251.59
Upside: -0.63%
Sep 2, 2020
Initiates: Neutral
Price Target: $43
Current: $1.55
Upside: +2,674.19%